Skip to main content
. 2022 Oct 7;13:1017331. doi: 10.3389/fendo.2022.1017331

Table 1.

Baseline clinical data of Cushing’s disease patients treated with ketoconazole.

Variable Total, n = 38 (%)
Sex (F/M) 32/6 (84.2/15.8%)
Age (years) 31.7 (11–51)
Ethnicity (White/non-White) 34/4 (89.5/10.5%)
Facial plethora 22 (57.9%)
Diabetes mellitus 12 (36%)
Hypertension 26 (78%)
Purpuric striae 21 (55.3%)
Acne 11 (28.9%)
Proximal weakness 19 (50%)
Supraclavicular fat 17 (44.7%)
“Buffalo hump” 22 (57.9%)
Psychiatric illness 12 (31.6%)
Microadenoma
Macroadenoma
Normal MRI
Unavailable
11 (28.94%)
15 (39.47%)
11 (28.94%)
1 (2.63%)